This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: New York University, University of Southern California. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,729 
1 out of 1,695 
Years Active: 2016
Title: The Innovative Journey of Ivan Grishagin
Introduction
Ivan Grishagin, an inventive mind based in Alhambra, CA, has made notable contributions to the field of genetic research. With a single patent to his name, he has paved the way for novel therapeutic methods aimed at regulating gene expression. His work holds potential in addressing various medical disorders, showcasing his commitment to innovation in genetics.
Latest Patents
Ivan Grishagin's patent titled "Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics" introduces innovative oligooxopiperazines that mimic the alpha B helix of the C-terminal transactivation domain of HIF-1α. This groundbreaking invention encompasses pharmaceutical compositions utilizing these compounds to reduce gene transcription, treat or prevent disorders mediated by the interaction of HIF-1α with CREB-binding protein and/or p300, and more. The applications of these findings extend to reducing angiogenesis in tissues, inducing apoptosis, and decreasing cell survival and proliferation.
Career Highlights
Throughout his career, Ivan has held significant positions at esteemed institutions such as New York University and the University of Southern California. His roles at these universities have provided him with a platform to advance his research and develop cutting-edge technologies that address critical challenges in gene therapy and cancer treatment.
Collaborations
Ivan Grishagin has had the privilege of collaborating with renowned colleagues, including Paramjit S. Arora and Bogdan Z. Olenyuk. These partnerships have not only enriched his research experience but have also contributed to the collective efforts in the quest for innovative solutions in medical science.
Conclusion
Ivan Grishagin's contributions to the field of genetics through his patent and collaborative efforts highlight the importance of innovation in advancing healthcare solutions. As research continues to evolve, the potential impacts of his work may lead to significant improvements in treatments for various disorders, showing that even a single patent can spark transformative changes in the medical landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile